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Yaron Sternbach, MD, Paul B. Kreienberg, MD, Benjamin B. Chang, MD, and
R. Clement Darling III, MD, Albany, NY
Purpose: Delayed abdominal aortic aneurysm (AAA) rupture is a well recognized complication of endovascular aneurysm
repair (EVAR). We wanted to evaluate the frequency, etiology, and outcomes of delayed AAA rupture following EVAR,
and identify treatment options that facilitate improved survival.
Methods: From 2002 to 2009, 1768 patients underwent elective and emergent EVAR. At a mean follow-up of 29 months,
27 (1.5%) patients presented with delayed AAA rupture and required repair by either open surgical conversion or
endovascular means. All data were prospectively collected in a vascular registry, and outcomes analyzed.
Results: Over a mean follow-up of 29 months, the incidence of delayed AAA rupture after elective EVAR was 1.4% (24
of 1615 patients), and after emergent EVAR for ruptured AAA was 2.8% (3 of 106 patients). Of the 27 delayed AAA
rupture patients, 20 (74%) were considered “lost to follow-up,” and, at presentation, 17 (63%) patients had Type 1
endoleak with stent graft migration, three (11%) had Type 1 endoleak without stent graft migration, five (19%) had
Type 2 endoleak, and two (7%) had undetermined etiology for aneurysm rupture. Fifteen (55%) patients underwent
open surgical repair via retroperitoneal approach with partial (n  8; 53%) or complete (n  7; 47%) stent graft
explants and aortoiliac reconstruction, 11 (41%) patients underwent a second EVAR, and one (4%) patient refused
treatment and died. Supraceliac aortic clamp was required in three (20%) patients with open surgical conversion, and
supraceliac occlusion balloon was required in two (18%) patients with EVAR. There were three (11%) postoperative
deaths; two following open surgical conversion and one following EVAR. One additional redo-EVAR patient has
undergone successful elective conversion to open surgical repair for persistent type II endoleak and increase in AAA
size.
Conclusions: Delayed AAA rupture following EVAR can be successfully managed in most patients by open surgical
conversion or secondary EVAR. The approach to each patient should be individualized; complete stent graft explant is not
necessary in most patients; a secondary EVAR for delayed AAA rupture with or without an elective conversion to open
surgical repair remains a viable option. Vigilant routine follow-up is needed for all patients after EVAR. (J Vasc Surg
2011;53:14-20.)The metamorphosis of abdominal aortic aneurysm
(AAA) repair from open surgical to endovascular means has
evolved substantially over the past 20 years. Today, endo-
vascular aneurysm repair (EVAR) is considered relatively
safe and effective for treatment of infrarenal AAA and is
often considered as the first choice therapy in patients with
favorable aortoiliac morphology. Furthermore, in “real
world” clinical scenarios, with increasing physician experi-
ence and ability, the indications of EVAR have expanded
from treatment of elective to emergent and from favorable
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14to sometimes complex and unfavorable aortoiliac anatomy,
particularly in high-risk patients. However, regardless of
our ability to perform EVAR with high technical success
rates, lifelong prevention of aneurysm-related mortality
remains questionable as stent graft failure secondary to
endoleaks, stent graft migration, endotension and sac en-
largement, infection, and stent graft tear and fractures
continue to be persistent problems that can result in aneu-
rysm rupture following EVAR.1-4
Over the past decade, several centers have published
their experiences in dealing with failures of EVAR resulting
in delayed elective and emergent secondary endovascular
procedures and conversions to open surgical repair, yet data
on treatment of aneurysm rupture following EVAR are
scarce, and a well-defined standardized approach to these
significant problems is lacking.2,3 At the Vascular Institute
for Health and Disease in Albany, we wanted to evaluate
the frequency, etiology, and outcomes of delayed AAA
rupture following EVAR, and identify treatment options
that facilitate improved survival.
METHODS
From 2002 to 2009, 1768 patients underwent elective
and emergent EVAR for treatment of aortoiliac aneurysms.
All procedures were performed in the operating room with
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femoral cut-down. Our routine postoperative follow-up
included patient clinical evaluation at 1 month, and every 6
months, and at least a computed tomography scan at 1
month, 6 months, 12 months, and yearly thereafter. Pa-
tients that miss any of these appointments are routinely
contacted via phone and/or letter, and consulted on the
importance of the continued clinical and image evaluation
for the EVAR and are rescheduled for routine evaluation.
The stent grafts used were either Food and Drug Admin-
istration approved, or ones undergoing evaluation as part of
the Food and Drug Administration-approved clinical trials.
At the Albany Vascular Institute for Health and Dis-
ease, our approach to patients with AAA rupture following
EVAR was individualized and based primarily on the pa-
tient’s anatomical suitability for EVAR at the time of aneu-
rysm rupture. All hemodynamically stable patients (systolic
blood pressure 80 mm Hg, alert and oriented) undergo
preoperative computed tomography angiography (CTA)
scan (0.625 mm axial, abdomen and pelvis), and patients
considered hemodynamically unstable (cardiovascular col-
lapse requiring aggressive ongoing resuscitation) have CTA
only if the clinical presentation allows, and are transferred
directly to the operating room that is equipped and ready
for both endovascular and open surgical procedures, as
needed. Regardless of the patient’s hemodynamic status,
anatomically suitable patients with ruptured AAA under-
went “EVAR-first” approach, which has been described
previously.5 Endovascular treatment was tailored based on
the etiology of stent graft failure, such as stent graft migra-
tion, endoleaks, etc, leading to AAA rupture. We consid-
ered stent graft migration to be significant requiring inter-
vention when it was associated in a Type 1 endoleak, and if
the aortic neck seal zone was 1 cm and stent graft migra-
tion was 1 cm, even without a diagnosed Type 1 en-
doleak. Aortic occlusion balloons during the secondary/
redo-EVAR were used as needed in hemodynamically
unstable patients, and endovascular procedures included
stent graft extensions at proximal or distal aortoiliac fixa-
tion sites, placement of juxtarenal Palmaz stent for fixation
as seal, and the conversion of bifurcated stent grafts into
aorto-uni-iliac devices and femoral-femoral crossover as
needed. Endovascular conversion to aorto-uni-iliac was
surgeon-dependent and generally reserved for patients with
significant stent graft migration where simply placing a
proximal aortic cuff was considered to be insufficient in
length to obtain a proximal seal.
When ruptured AAA after EVAR were not considered
anatomically suitable for secondary/redo-EVAR, patients
underwent open surgical conversion via left retroperitoneal
approach, the details of which are described later in the
Methods section. During open surgical conversion, aortic
control was obtained by either a suprarenal or a supraceliac
aortic clamp, or placement of an aortic occlusion balloon
via transfemoral approach. In AAA rupture patients with
infrarenal stent grafts, aortic clamps were generally placed
at the supra-renal level, the aneurysm sac opened, the entire
infrarenal stent graft was explanted including the iliaclimbs, and aortoiliac reconstruction performed as needed.
In instances when the iliac limbs could not be explanted
due to scarring, either the distal anastomosis was con-
structed beyond the iliac stent grafts and the aortic bifur-
cation oversewn, or the limbs transected at the aortic
bifurcation and aortic tube grafts sutured directly to the
distal aortic bifurcation, and the stent graft limbs were
incorporated within the anastomosis. In AAA rupture pa-
tients with stent grafts that had suprarenal self-expanding
stents for fixation, aortic control was obtained by placing a
supraceliac aortic clamp. In these cases, partial stent graft
explant via transaction of the stent graft within the proximal
aortic neck was primarily considered, and patients without
any infrarenal aortic neck underwent complete stent graft
explant, and the remainder of aortoiliac reconstruction was
performed as needed. In AAA rupture patients with stent
grafts that also had placements of balloon-expandable
Palmaz stents, aortic control was obtained via a supraceliac
aortic clamp, or an aortic occlusion balloon, with partial or
complete stent graft explant and aortoiliac reconstruction
as needed.
Redo-EVAR. In our experience, patients presenting
with aneurysm rupture after EVAR tend not to exhibit
profound signs of hemodynamic collapse, and their symp-
toms are generally that of abdominal and back pain. As long
as the patients maintain a measurable blood pressure, the
techniques of “hypotensive hemostasis” by limiting the
resuscitation to maintain a detectable blood pressure can
help minimize ongoing hemorrhage. Detailed evaluation
of the CTA to identify the etiology of stent graft failure and
aneurysm rupture is vital for planning for redo-EVAR. The
patient is prepped and draped in supine position, and, via a
femoral artery cut-down, ipsilateral access is obtained using
a needle, floppy guidewire, and a guiding catheter. The
floppy guidewire is exchanged for a super-stiff wire that can
be used to place a large sheath (12 to 14Fr 45 cm length)
in the ipsilateral femoral artery and the sheath advanced up
to the juxtarenal abdominal aorta so it is ready to be used to
deliver and support the aortic occlusion balloon if needed.
A compliant occlusion balloon should always be available in
these procedures, and, in hemodynamically unstable pa-
tients, the occlusion balloon is advanced through the ipsi-
lateral sheath over the super-stiff wire into the supraceliac
abdominal aorta under fluoroscopic guidance, and the bal-
loon is inflated as needed. Access is subsequently obtained
from contralateral femoral artery cut-down in similar fash-
ion, and a “marker flush-catheter” advanced to the juxta-
renal aorta for an arteriogram. Ipsilateral and contralateral
percutanious access can be obtained as well, depending on
local expertise. It has been our approach to perform these
procedures primarily via ipsilateral femoral artery cut-down
and contralateral percutaneous access if only diagnostic
catheters are needed that require smaller than 8 Fr sheaths.
The placement of the stent graft extensions; proximal,
distal, or within the stent graft components to achieve stent
graft fixation and seal and treat the ruptured aneurysm is
carried out on the basis of CTA, and intraoperative arterio-
gram findings and endovascular therapy is targeted toward
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hibitive, in hemodynamically stable patients, following the
initial arteriogram, the aortic occlusion balloon is removed
from the initial ipsilateral side and the stent graft main body
advanced under fluoroscopic guidance; this limits the num-
ber of catheter exchanges. In the rare hemodynamically
unstable patients that require inflation of the aortic occlu-
sion balloon, the “marker flush-catheter” is exchanged for
the stent graft main body/extension, which is delivered up
to the renal arteries. An arteriogram is done via the sheath
that is used to support the aortic occlusion balloon, the tip
of the stent graft main body/extension is aligned with the
lowermost renal artery, the occlusion balloon is subse-
quently deflated and withdrawn back with the delivery
sheath into the AAA, and the stent graft main body/
extension deployed. When bifurcated stent grafts are con-
verted to aorto-uni-iliac devices, a femoral-femoral bypass
is performed to maintain perfusion to the contralateral
limb. The use of Palmaz stents at the proximal aortic neck
to facilitate fixation and seal when needed is performed in
the following manner; 1) a Palmaz 4910 stent is hand-
crimped and centered onto a 20 to 25 mm noncompliant
Maxi-LD balloon (Cordis, Bridgewater, NJ); 2) both ends
of the Maxi-LD balloon with the Palmaz stent are slightly
inflated to avoid “watermelon seed” displacement of the
Palmaz stent during deployment; 3) a 16 to 18 Fr delivery
sheath is advanced into the straight and non-tortuous main
body of the stent graft; 4) the Palmaz stent loaded onto the
balloon is delivered to the juxtarenal aorta and aligned for
deployment partially in the stent graft main body and the
native aortic neck, and deployed under fluoroscopic guid-
ance; 5) the Maxi-LD balloon is exchanged for a compliant
aortic occlusion balloon, and the Palmaz stent is molded to
anchor the stent graft to the aortic neck wall.
Surgical conversion. Surgical conversions following
EVAR have been described by a few centers, all utilizing
the standard transperitoneal approach via midline laparo-
tomy.6,7 We preferentially utilize the retroperitoneal ap-
proach to the abdominal aorta for elective open repair of
aneurysm in our clinical practice. A familiarity with this
extended left retroperitoneal exposure in elective situations
involving infrarenal abdominal aortic aneurysms has al-
lowed us to extend the use of this approach to more
complex clinical scenarios involving juxtarenal and suprare-
nal aneurysm repair involving the visceral vessels. The same
attributes of the left retroperitoneal exposure that facilitate
repair in ruptured aneurysm, such as the ability to control
the entire abdominal aorta from the distal thoracic segment
to the iliac bifurcation, also apply to open repair in patients
with failed endovascular repair and rupture.
The primary concerns in treating patients with rupture
of the aortic sac after endovascular repair of aortic aneu-
rysms involve the operative approach after retroperitoneal
exposure and methods of revascularization. The degree of
difficulty in exposing the operative field in the retroperito-
neum in the setting of a previously deployed aortic en-
dograft varies depending upon the amount of inflammation
present, which is due either to the mere presence of theendograft within the aorta or a reactive response to prior
attempts at translumbar coil embolization of persistent
Type I or II endoleak. The appearancemay resemble that of
an inflammatory aneurysm; maneuvers to minimize injury
to adjacent structures (duodenum, ureter, and renal veins),
such as maintaining the dissection within the retroperito-
neum as posterior as possible, and attempts to identify the
ureter early with or without the use of preoperatively placed
stents facilitate the procedure.
In all procedures, the patient is placed on a suction
beanbag in a modified Sims position with the torso rotated
60 to 90 degrees and the pelvis tilted 30 to 45 degrees with
respect to the horizontal plane. The table break is placed
cephalad to the left anterior superior iliac spine, and the
table is flexed once the patient is oriented properly. The
skin incision is made obliquely from the ipsilateral lateral
margin of the rectus abdominus muscle toward the mid to
posterior axillary line along the 10th intercostal space pos-
teriorly.
The incision is deepened through the lateral muscula-
ture, and the retroperitoneal space is entered. Care is taken
to preserve the fascia overlying the psoas muscle as this
minimizes blood loss and the chance of genitofemoral and
ilioinguinal nerve injury. Ideally, in performing this repair,
it is advisable to obtain supraceliac aortic control without
entering the aortic hematoma. This is best done by advanc-
ing the surgeon’s left hand in a cephalad direction along the
psoas muscle toward the diaphragmatic crus. At this point,
the surgeon can obtain manual supra celiac control by
compressing the aorta posteriorly against the thoracic ver-
tebral bodies with the fingertips of the left hand. Then, the
muscular fibers of the diaphragmatic crus are divided trans-
versely, allowing precise placement of an aortic cross clamp.
At this point, attention can be turned to defining the
aorta at the level of the left renal artery. The lumbar branch
of the left renal vein is divided to allow anterior mobiliza-
tion of the kidney and exposure of the left renal artery and
the visceral segment of the aorta. If information is available
regarding the previously deployed endograft in terms of
suprarenal versus infrarenal fixation, this may help plan
subsequent control and clamping of the distal aorta. In
patients with a known suprarenal fixation, it is often pref-
erable to leave the aortic cross clamp on the supraceliac
aorta. With a known infrarenal device, assuming the aorta
can be accurately dissected, is minimally diseased and has
no significant aneurysmal component, the cross clamp can
be moved to the infrarenal aorta.
All data were prospectively collected in a vascular reg-
istry and outcomes evaluated for mode of stent graft failure,
presence of endoleaks, stent graft migration, and the type of
repair including redo-endovascular or open surgical con-
version. Statistical analysis was performed by means of t test
and Fisher’s exact test, and P values of .05 were consid-
ered statistically significant.
RESULTS
From 2002 to 2009, 1768 patients underwent
EVAR, and 27 (1.5%) presented with AAA rupture fol-
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elective in 24 (1.4%) patients and emergent in three
(2.8%) patients; the mean follow-up from initial EVAR
to aneurysm rupture was 29 months (range, 14-111
months). Patient demographics and comorbidities are
listed in Table I. Our standard postoperative follow-up
includes patient evaluation at 1 month, and every 6
months thereafter, with initial CT scan at 1 month, then
every 6 months for the first year, and subsequently a
yearly CT scan. Of the 27 patients that presented with
aneurysm rupture following EVAR, 20 (74%; P  .05)
patients had missed the routine scheduled office appoint-
ments and CT evaluation for 1 year and were consid-
ered lost to follow-up.
All ruptured aneurysm patients were divided into two
groups; Group 1: Redo-EVAR (n  11, 42%), and
Group 2: Surgical Conversion (n  15, 58%). Possible
identifiable causes for aneurysm rupture following EVAR
included: Type 1 endoleak with stent graft migration
(n  17; 63%); Type 1 endoleak without stent graft
migration (n  3; 11%); Type 2 endoleak only (n  5;
19%); and undetermined etiology (n  2; 7%, Table II).
Upon presentation at the time on aneurysm rupture, all
Group 1 and 2 patients had preoperative CTA evalua-
tion, and two (18%) patients in Group 1 and three (20%)
patients in Group 2 were considered hemodynamically
unstable. Intraoperative aortic occlusion balloon was







No. 11 (42%) 15 (58%)
Male 9 (82%) 12 (80%) NS
Age (mean) 78 years 74 years NS
Coronary artery disease 9 (82%) 11 (73%) NS
Hypertension 9 (82%) 10 (67%) NS
Chronic renal insufficiency 2 (18%) 2 (13%) NS
Chronic obstructive pulmonary
disease 1 (9%) — NS
EVAR, Endovascular aneurysm repair.
Table II. Etiology for AAA rupture following EVAR
Rupture after EVAR
No. 27 patients
Mean length of follow-up after
initial EVAR 29 months
Lost to follow-up for 1 year 20 (74%)
Etiology: Type 1 endoleak 17 (63%)
Type 2 endoleak 5 (19%)
Type 3 endoleak 0
Undetermined 2 (7%)
AAA max diameter at initial
EVAR (mean) 5.6 cm P  .05AAA max diameter at time of
rupture (mean) 6.4 cm
AAA, Abdominal aortic aneurysm; EVAR, endovascular aneurysm repair.needed in two (18%) Group 1 patients that underwentRedo-EVAR, and one (7%) Group 2 patient that under-
went surgical conversion. The mean AAA size at the time
of EVAR was 5.6 cm, and at the time of aneurysm
rupture following EVAR was 6.4 cm (P  .05). The 11
patients with redo EVAR had either proximal stent graft
extension (n  5; 45%), proximal stent graft extension
with Palmaz stent (n  4; 36%), or distal stent graft
extensions (n  2; 18%). Intraoperative variables such as
site of aortic clamp placement, partial or complete stent
graft explant, morbidity, and mortality are listed in Table
III, and these differences were not statistically signifi-
cant. All four deaths in the redo EVAR group (n  1)
and surgical conversion group (n 3) were secondary to
multisystem organ failure during the postoperative pe-
riod. In the remainder of the patients that survived, there
were no instances of myocardial infarction or renal fail-
ure requiring dialysis. Overall, there were five different
types of stent graft failures that required redo-EVAR or
stent graft explant (see Table IV).
DISCUSSION
The fundamental goal of AAA repair by either surgi-
cal or endovascular means is to reduce the risks for
aneurysm rupture and death. Prospective multicenter
trials have evaluated the safety, effectiveness, and dura-
bility of EVAR and led to United States Food and Drug
Administration approval of several devices in the United
States that are readily used in everyday clinical prac-
tice.8-12 However, none of the currently available devices
is completely effective in preventing aneurysm rupture
following EVAR, and lifelong surveillance of these stent
Table III. Intraoperative variable during redo-EVAR









No. 11 (42%) 15 (58%) 26
Stent graft infrarenal
fixation 8 10 NS 17
Stent graft suprarenal




angiography 100% 100% NS 100%
Unstable 2 (18%) 3 (20%) NS 5 (19%)
Aortic occlusion
balloon 2 (18%) 1 (7%) NS 3 (12%)
Supraceliac clamp — 3 (20%) N/A 3 (12%)
Partial stent graft
explant — 8 (53%) N/A 8 (30%)
Complete stent graft
explant — 7 (47%) N/A 7 (26%)
Mean estimated
blood loss 277 cc 2280 cc 1433 cc
Mean operative time 84 min 220 min 162 min
30-day mortality 1 (9%) 3 (20%) NS 4 (15%)
AAA, Abdominal aortic aneurysm; EVAR, endovascular aneurysm repair.grafts and aneurysms is needed.2,13-16
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2002 indicates that over a mean follow-up of 29 months,
1.5% of patients can present with aneurysm rupture.
Unlike patients with primary AAA rupture that are often
hemodynamically unstable at the time of presentation,
82% of the patients with a prior EVAR procedure were
considered to be hemodynamically stable, and 100%
underwent evaluation by CTA prior to repair.17 The
most common adverse factors contributing to aneurysm
rupture after EVAR included type I endoleak with stent
graft migration (63%), type II endoleak (19%), type I
endoleak without stent graft migration (11%), and in 7%
of patients, the etiology for aneurysm rupture after
EVAR was undetermined. Treatment options were de-
signed on the basis of underlying etiology; 41% of the
patients with aneurysm rupture after EVAR underwent
redo-EVAR, while 55% required conversion to surgical
repair. There was a trend toward a higher mortality in
patients that underwent open surgical conversion (20%)
when compared with redo-EVAR (9%), but this differ-
ence was not statistically significant.
Our data suggest few significant findings: 1) failure
of routine postoperative AAA surveillance as 74% (20 of
27) of the patients were considered lost to follow-up and
had missed routine clinical evaluation, and 2) failure of
proximal seal as 74% (20 of 27) of the patients presented
with a Type 1 endoleak at the time of aneurysm rupture.
Our routine postoperative EVAR surveillance includes
clinical evaluation and duplex ultrasound at 1 month and
every 6 months, as well as a CTA evaluation at 1 month,
6 months, 12 months, and yearly thereafter. The mean
time interval of patients considered lost to follow-up was
29 months. It is our routine practice to attempt contact-
ing patients that deviate from the routine follow-up
schedule; unfortunately, we are not always successful, as
a significant proportion of the EVAR patient population
is elderly (mean age, 74 years) with significant comor-
bidities, and often travel great distances to tertiary hos-
pitals for EVAR. The presence of Type I endoleak with or
without stent graft migration was a significant risk factor
for AAA rupture; it is our routine practice to treat any
Type I endoleak at the time of diagnosis via addition of
proximal aortic cuffs, use of juxtarenal Palmaz stent, and
Table IV. Association between the type of stent grafts,







EVT — 1 Migration/Type 1 endoleak
Corvita — 2 Migration/Type 1 endoleak
Aneurex 8 6 Migration/Type 1 endoleak
Zenith — 5 3 Migration/Type 1 endoleaks
2 Type 2 endoleaks
Gore 2 1 2 Type 2 endoleaks
1 Type 1 endoleak
EVAR, Endovascular aneurysm repair.coil embolization as needed. Unfortunately, a significantpercentage of patients was considered lost to follow-up,
and the timing of Type I endoleak genesis could not be
determined. As for treating stent graft migration from
the proximal fixation site without evidence of Type I
endoleak, it is our routine practice to add additional
proximal stent graft extensions if the aortic neck seal
zone is 1 cm and the stent graft migration is 1 cm.
Based on our past experiences of open surgical aortic
reconstruction, we have adopted several fundamental
principals when deciding on partial or complete stent
graft explant following EVAR. The single most impor-
tant factor in deciding between partial or complete stent
graft explant is generally considered to be the intended
side of aortic clamping, and the associated morbidity and
mortality. Other considerable factors include the type of
stent graft fixation (suprarenal versus infrarenal, and
active with hooks/barbs vs passive with self-expanding
stent only), as this too influences the sight of aortic
clamping and the possible adjunctive need for visceral
endarterectomy and/or revascularization with complete
stent graft explant.18,19 It is our fundamental belief that
infrarenal aortic clamping with partial stent graft explant
might be a significantly less morbid procedure when com-
pared with supravisceral aortic clamp and complete stent
graft explant, with possible visceral reconstructions, partic-
ularly in many of these high-risk aneurysm patients.20
If the etiology of the aneurysm rupture is secondary
to Type I, II, or III endoleak and can be determined by
a preoperative CT scan, the surgeon may have some
foresight into further options for subsequent revascular-
ization. Often the etiology of the aneurysm sac rupture is
only determined after opening the aortic sac. This should
be done carefully in order to not disrupt an endograft
that is adequately sealed proximally. In the presence of
suprarenal fixation with a Type I or III endoleak, one
may be able to remove the proximal aspect of the device
by way of resheathing the endograft or using wire cutters
to remove the stent graft and leave the bare stent in
situ.21 If the barbs of the device are too well incorpo-
rated into the aortic wall, the surgeon can longitudinally
incise the lateral aortic wall in a cephalad direction with
or without aortic endarterectomy to facilitate proximal
removal of the device. The lateral aortotomy can be
closed as described for “trap door” endarterectomy with
left renal bypass as necessary. Alternatively, the proximal
end of the device can be left in place, and the proximal
end of the prosthetic graft sewn to the infrarenal aorta/
proximal device composite. The remainder of the en-
dograft can be completely explanted. In this case, a
bifurcated prosthetic graft is sewn as previously de-
scribed proximally, and the distal ends sewn to the
non-diseased iliac or femoral arteries. Rarely, if there is
minimal aneurysmal dilation of the iliac arteries, a tube
graft can be sewn to the aortic bifurcation distally.
In the presence of an aneurysm sac rupture due to Type
I or III endoleak after infrarenal device fixation, the proxi-
mal end of the new graft is sewn to the infrarenal aorta if it
is minimally diseased or to the suprarenal aorta in a beveled
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as necessary. The aorta may need to be clamped at the
suprarenal level to facilitate the performance of the proxi-
mal anastomosis. The graft can be completely explanted at
this point, and a tube or bifurcated graft sewn in place as
previously described.
In patients with aneurysm sac rupture after Type II
endoleak, the previously-placed endograft may be secure
proximally and distally. It, therefore, may not be neces-
sary to partially or completely explant the device. In this
situation, temporarily opening the proximal aortic clamp
to check the respective anastomosis and rule out Type I
or III endoleak is advisable. If the source of bleeding is
seen to be from the lumbar or inferior mesenteric arter-
ies, these are suture-ligated. Alternatively, these arteries
may be controlled exterior to the sac with hemoclips.
Partial stent graft explant may be performed on occasion
and may both facilitate and expedite the operative pro-
cedure. In situations where sac rupture is secondary to
Type IA endoleak, one solution is to trim the proximal
bare metal stent and either directly sew the primal end of
the device to native aorta with a 4-0 or 3-0 polypro-
pylene suture or use a short interposition PTFE graft.
The other solution in this situation is to sew a bifurcated
graft to the native proximal aorta and divide each of the
distal endograft limbs. Separate end to end anastomosis
is constructed with 5-0 polypropylene suture. Depend-
ing on the amount of seal zone of the iliac limb, the
native iliac artery can be secured externally to the en-
dograft limb with interrupted or continuous 5-0
polypropylene sutures. After any of these revasculariza-
tion procedures, the native aortic sac is closed over the
graft reconstruction to limit the bleeding from the raw
surface of the aneurysm interior, which is often friable
and prone to diffuse bleeding.
CONCLUSION
Delayed AAA rupture following EVAR can be success-
fully managed in most patients by open surgical conversion
or secondary EVAR. The approach to each patient needs to
be individualized, and complete stent graft explant is not
necessary in most patients that undergo open surgical con-
version. In select patients, particularly when the etiology
for aneurysm rupture can be identified, a redo-EVAR for
delayed AAA rupture remains a viable option. Although
Type I endoleaks with and without stent graft migration are
most frequently responsible for aneurysm rupture follow-
ing EVAR, nearly one-fifth of aneurysm ruptures in our
patient population were secondary to Type II endoleaks,
and vigilant routine follow-up and appropriate treatment is
needed for all patients after EVAR.
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